Mark Gelder

Company: Onconova Therapeutics Inc

Job title: Chief Medical Officer

Seminars:

Implementing Intermittent Dosing Schedules for Anti-RAS Therapeutics 12:00 pm

Read more

day: Pre-Conference Day Track E